John Reagan

15PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 04, 2021
Tumor lysis syndrome risk in outpatient versus inpatient administration of venetoclax and hypomethlators for acute myeloid leukemia.

Ari Pelcovits, Jozal Moore, Brianna Bakow

|Sep 12, 2020
Outcomes of lenalidomide- or bortezomib-based regimens in older patients with plasma cell myeloma.

Peter Barth, Smith Giri, John L Reagan

|Sep 02, 2020
Antibiotic use during cytarabine consolidation in acute myeloid leukemia.

Colin A Vale, Pamela C Egan, Randall Ingham

Pageof 3